Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FMP010
- Development stage
- Phase 1
- Lead developer
- Walter Reed Army Institute of Research
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
FMP010 is a recombinant protein subunit vaccine candidate developed by the Walter Reed Army Institute of Research (WRAIR) for the prevention of malaria caused by *Plasmodium falciparum*. The vaccine antigen is based on the Thrombospondin-Related Adhesion Protein (TRAP), a pre-erythrocytic stage protein that plays a critical role in sporozoite motility and the invasion of hepatocytes. FMP010 is typically formulated with the AS01B adjuvant system, a liposomal adjuvant containing monophosphoryl lipid A (MPL) and QS-21, to enhance the induction of protective humoral and cellular immune responses. Clinical trials have evaluated the safety and immunogenicity of FMP010 in both malaria-naive adults in the United States and malaria-experienced adults in Kenya.
- Other names
- Plasmodium falciparum malaria protein 010TRAP vaccineThrombospondin-related adhesion protein vaccine
02
Targets
TRAP (Thrombospondin-related anonymous protein)
Beyond the preview
Go deeper on FMP010.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FMP010.